LIVE MARKET TRACKER :   BSE SENSEX   33227.99      |    NSE NIFTY 10240.15    
GLOBAL MARKETS :  NASDAQ      |    FSI London      |    NIKKEI Japan  
  USD GBP EUR CAD AUD INR
USD -
GBP -
EUR -
CAD -
AUD -
INR -
Indian-Commodity  :  Economy  :  Sebi bans FPIs from issuing ODIs having derivatives as underlying assets

Sebi bans FPIs from issuing ODIs having derivatives as underlying assets (10-Jul-2017)

Furthering its restrictions on participatory notes or Offshore Derivative Instruments (ODIs), markets regulator Securities and Exchange Board of India (SEBI) has banned foreign portfolio investors (FPIs) from issuing such instruments where the underlying assets are derivatives.

In its latest circular 'Guidelines for issuance of ODIs, with derivative as underlying, by the ODI issuing FPIs', the SEBI said that P-Note issuances on derivatives can be issued only for the purpose of hedging with respect to the equity shares held. Besides, it said that in cases where the underlying derivatives position are not for purpose of hedging the equity shares, the issuing FPI has to liquidate such ODIs latest by the date of maturity or by December 31, 2020, whichever is earlier.

The circular further said that a certificate has to be issued by the compliance officer (or equivalent) of the ODI-issuing FPI in the case of issuance of fresh ODIs with derivatives as underlying and it should be certified that the derivatives position, on which the ODI is being issued, is only for hedging the equity shares held by it, on a one-to-one basis. Besides, SEBI also asked to submit the monthly ODI reports along with this certificate.


Top News Today
Alembic Pharma gets USFDA's nod for Darifenacin Extended Tablets
(12-Dec-2017)

Alembic Pharma gets USFDAAlembic Pharmaceuticals has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Darifenacin Extended-Release Tablets, 7.5 mg and 15......click on news to read complete article.

Bajaj Hindusthan Sugar planning to issue OCDs worth Rs 3483.25 crore
(12-Dec-2017)

Bajaj Hindusthan Sugar planning to issue OCDs worth Rs 3483.25 croreBajaj Hindusthan Sugar is planning to issue Optionally Convertible Debentures (OCDs) aggregating to Rs 3483.25 crore to the Lenders of the Company upon conversion of Part - B (Unsustainable portion) of......click on news to read complete article.

Cholamandalam Invetsment planning to issue masala bonds
(12-Dec-2017)

Cholamandalam Invetsment planning to issue masala bondsCholamandalam Investment and Finance Company is planning to issue masala bonds in the nature of non-convertible debentures on a private placement basis. The meeting of the Board of Directors of the Company......click on news to read complete article.

International Stock News
US markets closed higher on Monday
(12-Dec-2017)

US markets closed higher on MondayThe US markets closed higher on Monday, with the S&P 500 index and Dow industrials closing at records on the back of a rally in telecommunications and technology shares. Wall Street shrugged off......click on news to read complete article.

Asian markets trade higher in early deals on Monday
(11-Dec-2017)

Asian markets trade higher in early deals on MondayAsian equity benchmark indices are trading higher in the early deals on Monday, lifted by encouraging employment data from the US that took the Standard & Poor's 500 Index to its third straight......click on news to read complete article.

US markets end at record highs on upbeat jobs data
(09-Dec-2017)

US markets end at record highs on upbeat jobs dataThe US markets traded with traction and ended near record high levels on Friday, as traders reacted positively to the closely watched monthly jobs report. The continued advance by stocks came following......click on news to read complete article.

 

     
  
Recent Economy News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.